The present invention relates to a group of 1-[(E)-3-(3,4,5-trimethoxyphenyl)prop-2-enoyl]-2,3- dihydropyridin-6-one (piperlongumine) derivatives, analogs and pharmaceutically acceptable salts thereof. The present invention also relates to processes for preparing the same; a pharmaceutical composition and formulation containing a derivative of piperlogumine; and use of the derivatives and analogs for treating cancer.
本发明涉及一组1-[(E)-3-(3,4,5-三
甲氧基苯基)丙-2-烯酰基]-2,3-
二氢吡啶-6-酮(长椒碱)衍
生物、类似物及其药学上可接受的盐。本发明还涉及制备这些衍
生物的方法;含有长椒碱衍
生物的药物组合物和配方;以及利用这些衍
生物和类似物治疗癌症。